Exogenous Induction of Cerebral ß-Amyloidogenesis Is Governed by Agent and Host

The Amyloid Hypothesis of Alzheimer’s Disease: Progress and Problems on the Road to Therapeutics

Hardy, J., & Selkoe, D. J. (2002) · Science · doi:10.1126/science.1072994 · Cited by 13,864

Naturally secreted oligomers of amyloid β protein potently inhibit hippocampal long-term potentiation in vivo

Walsh, D. M., Klyubin, I., Fadeeva, J. V., Cullen, W. K., Anwyl, R., Wolfe, M. S., Rowan, M. J., & Selkoe, D. J. (2002) · Nature · doi:10.1038/416535a · Cited by 4,291

Diffusible, nonfibrillar ligands derived from Aβ 1–42 are potent central nervous system neurotoxins

Lambert, M. P., Barlow, A. K., Chromy, B. A., Edwards, C., Freed, R., Liosatos, M., Morgan, T. E., Rozovsky, I., Trommer, B., Viola, K. L., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.11.6448 · Cited by 3,506

Immunization with amyloid-β attenuates Alzheimer-disease-like pathology in the PDAPP mouse

Schenk, D., Barbour, R., Dunn, W., Gordon, G., Grajeda, H., Guido, T., Hu, K., Huang, J., Johnson-Wood, K., Khan, K., et al. (1999) · Nature · doi:10.1038/22124 · Cited by 3,160

Pathways towards and Away from Alzheimer’s Disease

Mattson, M. P. (2004) · Nature · doi:10.1038/nature02621 · Cited by 3,052

Natural oligomers of the amyloid-β protein specifically disrupt cognitive function

Cleary, J. P., Walsh, D. M., Hofmeister, J. J., Shankar, G. M., Kuskowski, M. A., Selkoe, D. J., & Ashe, K. H. (2004) · Nature Neuroscience · doi:10.1038/nn1372 · Cited by 1,722

Self-Propagating, Molecular-Level Polymorphism in Alzheimer's ß-Amyloid Fibrils

Petkova, A. T., Leapman, R. D., Guo, Z., Yau, W.-M., Mattson, M. P., & Tycko, R. (2005) · Science · doi:10.1126/science.1105850 · Cited by 1,687

MODELS OF AMYLOID SEEDING IN ALZHEIMER'S DISEASE AND SCRAPIE: Mechanistic Truths and Physiological Consequences of the Time-Dependent Solubility of Amyloid Proteins

Harper, J. D., & Lansbury, P. T. (1997) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.66.1.385 · Cited by 1,652

Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology

Sturchler-Pierrat, C., Abramowski, D., Duke, M., Wiederhold, K.-H., Mistl, C., Rothacher, S., Ledermann, B., Bürki, K., Frey, P., Paganetti, P. A., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.24.13287 · Cited by 1,507

Protein aggregation in health and disease: A looking glass of two faces

de Andrade, G. C., Mota, M. F., Moreira-Ferreira, D. N., Silva, J. L., de Oliveira, G. A. P., & Marques, M. A. (2024) · Advances in protein chemistry and structural biology · doi:10.1016/bs.apcsb.2024.09.010 · Cited by 2

The Prion-Like Aspect of Alzheimer Pathology

Fritschi, S. K., Eftekharzadeh, B., Manfredi, G., Hamaguchi, T., Heilbronner, G., Nagarathinam, A., Langer, F., Eisele, Y. S., Walker, L. C., & Jucker, M. (2013) · Research and perspectives in Alzheimer's disease · doi:10.1007/978-3-642-35491-5_5 · Cited by 2

Are Amyloids Infectious?

Morales, R., Chen, B., & Soto, C. A. (2009) · Springer eBooks · doi:10.1007/978-0-387-87995-6_14 · Cited by 2

The Contribution of the Amyloid Hypothesis to the Understanding of Alzheimer's Disease: A Critical Overview

Morelli, L., Perry, G. L., & Tagliavini, F. (2012) · International Journal of Alzheimer s Disease · doi:10.1155/2012/709613 · Cited by 2

Methods and Protocols for Developing Prion Vaccines

Marciniuk, K., Taschuk, R., & Napper, S. (2016) · Methods in molecular biology · doi:10.1007/978-1-4939-3387-7_37 · Cited by 2

The Amyloid _-Protein and Alzheimer's Disease

Teplow, D. B., Yang, M., Roychaudhuri, R., Pang, E. S., Huynh, T. V., Chen, M., & Beroukhim, S. (2012) · Frontiers in neuroscience · doi:10.1201/b11986-2 · Cited by 2

Übergreifende Konzepte der Neurodegeneration

Becktepe, J. S., Gövert, F., & Deuschl, G. (2017) · Aktuelle Neurologie · doi:10.1055/s-0042-123500 · Cited by 2

Neuropharmacology in Flux: Molecular Modeling Tools for Understanding Protein Conformational Shifts in Alzheimer’s Disease and Related Disorders

Lushington, G. H., Parker, F. E. S., Lushington, T. H. W., & Wallace, N. M. (2017) · Neuromethods · doi:10.1007/978-1-4939-7404-7_20 · Cited by 2

Neurodegeneration and the Ordered Assembly of Tau

Goedert, M. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-811304-2.00004-3 · Cited by 3

Biomarqueurs du liquide cérébrospinal dans la maladie d’Alzheimer

Hugon, J., Dumurgier, J., Cognat, E., & Paquet, C. (2018) · Bulletin de l Académie Nationale de Médecine · doi:10.1016/s0001-4079(19)30359-0 · Cited by 2

Protein Misfolding Cyclic Amplification

Moda, F., Pritzkow, S., & Soto, C. A. (2023) · Springer eBooks · doi:10.1007/978-3-031-20565-1_31 · Cited by 1

Seeding Activity of Skin Misfolded Proteins as a Biomarker in Prion and Prion-Like Diseases

Zou, W., & Wang, Z. (2023) · Springer eBooks · doi:10.1007/978-3-031-20565-1_32 · Cited by 1

Evaluating the inter-species transmission risk of amyloid beta peptide aggregates via ingestion

Raine, J., Tolwinski, N. S., Gruber, J., & Mathuru, A. S. (2024) · Alzheimer s Research & Therapy · doi:10.1186/s13195-024-01487-8 · Cited by 2

The Ubiquitin–Proteasome System in Neurodegenerative Diseases: More than the Usual Suspects

Bertolotti, A. (2011) · Wiley eBooks · doi:10.1002/9781118063903.ch5 · Cited by 2

Alzheimer disease models and human neuropathology: similarities and diVerences

Duyckaerts, C. J., Potier, M., & Delatour, B. (2008) · Cited by 2

Toxic effects of endoplasmic reticulum stress transducer BBF2H7-derived small peptide fragments on neuronal cells

Matsuhisa, K., Cai, L., Saito, A., Sakaue, F., Kamikawa, Y. F., Fujiwara, S., Asada, R., Kudo, Y., & Imaizumi, K. (2020) · Brain Research · doi:10.1016/j.brainres.2020.147139 · Cited by 2

Soluble amyloid‐β dimers are resistant to amyloid‐β prion conversion in vivo suggesting antiprion properties

van Gerresheim, E. F., Müller‐Schiffmann, A., Schäble, S., Koopmans, B., Loos, M., & Korth, C. (2023) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12895 · Cited by 1

Peripheral administration of blood from tau transgenic animals exacerbates brain tau-associated pathology

Vegas‐Gomez, L., Pizarro, M., Garcia-Martin, J., Arredondo-Alcala, M. A., Bustamante, B., Gonzalez‐Silva, C., Matus, S., Díaz‐Espinoza, R., Gutiérrez, A., Morales, R., et al. (2025) · PLoS ONE · doi:10.1371/journal.pone.0328470 · Cited by 2

Decoding the Relationship between Alzheimer’s Disease and Type-2 Diabetes via the Protein Aggregation Prism

Tammara, V., & Das, A. (2025) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.5c00357 · Cited by 1

Widening Spectrum of Prions Causing Neurodegenerative Diseases

Prusiner, S. B. (2013) · Research and perspectives in Alzheimer's disease · doi:10.1007/978-3-642-35491-5_1 · Cited by 1

Cofactor Involvement in Prion Propagation

Supattapone, S., & Miller, M. B. (2012) · Springer eBooks · doi:10.1007/978-1-4614-5305-5_7 · Cited by 1

How does the genetic assassin select its neuronal target?

Stevens, J. C., Fisher, E., & Mead, S. (2011) · Mammalian Genome · doi:10.1007/s00335-011-9319-5 · Cited by 1

Topographical Propagation of α-synuclein Pathology in Parkinson's Disease: Phenomenology and Hypothetical Mechanism

Hyun, M., & Lee, S. (2009) · Experimental Neurobiology · doi:10.5607/en.2009.18.1.19 · Cited by 1

Protein seeding in Alzheimer’s disease and Parkinson’s disease: Similarities and differences

Ibrahim, T. (2014) · World Journal of Neurology · doi:10.5316/wjn.v4.i4.23 · Cited by 1

Advances in induced pluripotent stem cell research for neurological diseases

Ito, D., Yagi, T., Nihei, Y., Yoshizaki, T., & Suzuki, N. (2010) · Rinsho Shinkeigaku · doi:10.5692/clinicalneurol.50.449 · Cited by 1

Malattie da prioni o encefalopatie spongiformi trasmissibili

Brandel, J., & Haı̈k, S. (2016) · EMC - Neurologia · doi:10.1016/s1634-7072(16)77562-3 · Cited by 1

Alzheimer’s Disease and Mechanism-Based Attempts to Enhance Cognition

Draffin, J. E., Knafo, S., & Heneka, M. T. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-417042-1.00009-7 · Cited by 1

The Role of Aβ in the Development of Alzheimer’s Disease and its Mechanisms

Jin, Y. (2020) · E3S Web of Conferences · doi:10.1051/e3sconf/202021803041 · Cited by 1

Transmission iatrogène des protéines β-amyloïde et tau : importance clinique et pour la recherche biomédicale sur la maladie d’Alzheimer

Dhénain, M. (2021) · Bulletin de l Académie Nationale de Médecine · doi:10.1016/j.banm.2021.04.018 · Cited by 1

Prion Diseases

Kong, Q., & Bessen, R. A. (2016) · Springer eBooks · doi:10.1007/978-3-319-44022-4_34 · Cited by 1

Alzheimer’s Disease and Frontotemporal Lobar Degeneration: Mouse Models

Ittner, L. M., Lee, W. S., Stefanoska, K., Asih, P. R., & Ke, Y. D. (2018) · Springer eBooks · doi:10.1007/978-3-319-72938-1_10 · Cited by 1

Prion diseases

Liberski, P. P., Ritchie, D. L., & Sikorska, B. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-85654-6.00004-6 · Cited by 1

Insoluble Cellular Prion Protein and Other Neurodegeneration-Related Protein Aggregates in the Brain of Asymptomatic Individuals

Zou, W. (2023) · Springer eBooks · doi:10.1007/978-3-031-20565-1_4 · Cited by 1

The Unfolding Story of Protein Misfolding Causing Alzheimer Disease in Recipients of Human Pituitary Growth Hormone

Graber, E., Hosseini, S. M. H., Wilson, D. M., & Rogol, A. D. (2025) · Journal of the Endocrine Society · doi:10.1210/jendso/bvaf029 · Cited by 1

The remarkable properties of amyloid-β derived from human Alzheimer’s disease brain: swinging the streetlight

Brody, D. L., & Gross, M. L. (2014) · Brain · doi:10.1093/brain/awu261 · Cited by 1

Hat die Alzheimer-Forschung versagt?: Das Scheitern amyloidbasierter klinischer Studien

Haass, C., & Levin, J. (2019) · Der Nervenarzt · Cited by 1

How molecular imaging studies can disentangle disease mechanisms in age-related neurodegenerative disorders

de Natale, E. R., Wilson, H., Udeh‐Momoh, C. T., Ford, J. K., Politis, M., & Middleton, L. T. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-823761-8.00022-7 · Cited by 1

Statistical and Data Mining Methodologies for Behavioral Analysis in Transgenic Mouse Models of Alzheimer’s Disease: Parallels with Human AD Evaluation

Leighty, R. E. (2009) · Digital Commons - University of South Florida (University of South Florida) · Cited by 1

Imaging of Misfolded Proteins

LeVine, H. (2010) · doi:10.1002/9780470572702.ch30 · Cited by 1

Conjugated Polyelectrolyte‐Based Imaging and Monitoring of Protein Aggregation

Nilsson, K. P. R., & Hammarström, P. (2012) · doi:10.1002/9783527655700.ch9 · Cited by 1

Chemistry of Alzheimer Disease

Sack, G. H. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-378630-2.00032-3 · Cited by 1

Understanding the role of MiR-16-5p in prion-induced neurodegeneration

Burak, K. (2017) · Mspace (University of Manitoba) · Cited by 1

Telomere length and oxidative stress variations in a murine model of Alzheimer’s disease progressionPreprint

Martínez‐González, K., Islas‐Hernández, A., Martínez‐Ezquerro, J. D., Bermúdez‐Rattoni, F., & Garcia-delaTorre, P. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/684365 · Cited by 1

The Effect of Scyllo-inositol on the Neurodegeneration Induced by Alpha-synuclein Fibril Transmission in Mice

Ibrahim, T. (2015) · TSpace (University of Toronto) · Cited by 1

Long term worsening of Alzheimer pathology and clinical outcome by a single inoculation of mutated beta-amyloid seedsPreprint

Célestine, M., Jacquier‐Sarlin, M. R., Borel, E., Petit, F., Pérot, J., Hérard, A., Bousset, L., Buisson, A., & Dhénain, M. (2022) · Research Square · doi:10.21203/rs.3.rs-2334976/v1 · Cited by 1

APP accumulates around dense-core amyloid plaques with presynaptic proteins in Alzheimer’s disease brainPreprint

Jordá-Siquier, T., Petrel, M., Kouskoff, V., Cordelières, F. P., Frykman, S., Müller, U. C., Mulle, C., & Barthet, G. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.10.16.342196 · Cited by 2

The dynamic nature of amyloid-beta protein aggregation and its association to Alzheimer’s disease

Vilaprinyó-Pascual, S. (2015) · Tesis Doctorals en Xarxa (Consorci de Serveis Universitaris de Catalunya)

Alzheimer’s Disease and Frontotemporal Lobar Degeneration: Mouse Models

van Eersel, J., Delerue, F., Ittner, L. M., & Ke, Y. D. (2014) · Springer eBooks · doi:10.1007/978-1-4471-6380-0_8

Animal Models of Amyloid Diseases

Ott, S., & Crowther, D. C. (2013) · Wiley eBooks · doi:10.1002/9783527654185.ch12

Amyloid Polymorphisms: Structural Basis and Significance in Biology and Molecular Medicine

Stefani, M. (2011) · Wiley eBooks · doi:10.1002/9783527634323.ch5

Cytotoxic properties of amyloidogenic L68Q cystatin C. A search for therapeutic agents

Ingólfsdóttir, I. E. (2013)

pH modulation of fibril dissociation and copper binding properties of the prion protein

Qi, X. (2012) · The Mathematics Enthusiast

Mechanisms of Brain Region-Specific Amyloid-beta Deposition

Bero, A. W. (2011) · Open Scholarship Institutional Repository (Washington University in St. Louis) · doi:10.7936/k7cj8bh2

Biophysical understanding of novel synthetic amyloid-beta (Abeta) prions in Alzheimer's disease

Kumar, A. (2013)

Le phénomène Prion, différents aspects d'un nouveau concept en biologie

Moudjou, M., & Ermonval, M. (2010) · HAL · doi:10.1684/vir.2010.0313

Accumulating Evidence Suggests that Parkinson’s Disease Is a Prion-Like Disorder

Rey, N. L., Angot, É., Dunning, C. J. R., Steiner, J. A., & Brundin, P. (2013) · Research and perspectives in Alzheimer's disease · doi:10.1007/978-3-642-35491-5_8

Transmissible Spongiform Encephalopathies

Aguzzi, A. (2009) · doi:10.1128/9781555815981.ch57

Alzheimer disease: Studies on Aand -secretase in human brain

Welander, H. (2009)

Enfermedades por priones: de la clínica a la biología molecular Prion diseases: from molecular biology to clinical practice

Andrés, C., & Lanau, V. (2010)

Dynamics of amyloid plaque formation in Alzheimer’s Disease

McCarter, J. F. (2014) · Elektronische Hochschulschriften der LMU München (Ludwig-Maximilians-Universität München) · doi:10.5282/edoc.17434

The interplay between vascular and mitochondrial abnormalities in type 2 diabetes and Alzheimer’s disease

Carvalho, C. (2013) · Estudo Geral (Universidade de Coimbra)

Bone Marrow-Derived Cell Accumulation in the Brain in a Murine Model of Alzheimer’s Disease

Barr, C. (2013) · Summit (Simon Fraser University)

Die nächste Prionenerkrankung?

Pilotto, A. (2016) · InFo Neurologie + Psychiatrie · doi:10.1007/s15005-016-1605-z

Amyloid-β Protofibril Formation and Neurotoxicity : Implications for Alzheimer’s Disease

Johansson, A. (2007) · KTH Publication Database DiVA (KTH Royal Institute of Technology)

Protein-misfolding in neurodegenerative disease

(2009) · The Internet Journal of Neurology · doi:10.5580/23f3

Propagation and Replication of Misfolded SOD1: Implications for Amyotrophic Lateral Sclerosis

Bertolotti, A. (2013) · Research and perspectives in Alzheimer's disease · doi:10.1007/978-3-642-35491-5_9

Protein Misfolding and Amyloid Formation in Alzheimer’s Disease

Tayubi, I. A., Firoz, A., & Malik, A. (2015) · Springer eBooks · doi:10.1007/978-81-322-2467-9_7

New Evidence Suggests Link between Prion Disease and Alzheimer’s Disease

Liu, H. (2016) · MOJ Cell Science & Report · doi:10.15406/mojcsr.2016.03.00056

Aβ Fibril Polymorphism and Alzheimer’s Disease

Bereza, M., & Fändrich, M. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-394431-3.00017-1

Approaches to therapy against prion diseases focused on the individual defence system

Monzón, M. (2017) · AIMS molecular science · doi:10.3934/molsci.2017.3.241

Cell model for the identification and characterization of prion-like components from Alzheimer brain tissue

Markx, D., Loos, C., Claus, S., Haupt, C., Mawrin, C., & Fändrich, M. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.02.137

Development and characterization of cell models of tau aggregation

Cavallini, A. (2018) · UCL Discovery (University College London)

Neuro-pathological Implications of β-Amyloid Protein: An Update

Maurya, N., & Agarwal, N. R. (2018) · Proceedings of the Nature Research Society · doi:10.11605/j.pnrs.2018020061 · Cited by 2

An Amyloid beta-derived Septapeptide has hMCP-1 Chemokine ActivityPreprint

Alstyne, D. V. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/424838

The Prion Diseases

Lewis, P. A., & Spillane, J. E. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-811069-0.00004-5

‘Transmissible’ Alzheimer’s theory gains traction

Abbott, A. (2018) · Nature · doi:10.1038/d41586-018-07735-w

Proteomic-based Signature of Brain-related Proteins as Novel Candidate Biomarkers for Alzheimer’s Disease Diagnosis

Begcevic, I. (2018) · TSpace (University of Toronto)

Cell replacement therapy for Huntington's disease : what we have learned from post-mortem analyses of grafted patients and mice models

Cisbani, G. (2014)

THE CONTRIBUTION OF MOSAIC MUTATION TO AUTISM SPECTRUM DISORDER

Freed, D. N. (2017)

Molecular mechanisms of fibrillation of IDPs

Salvi, N. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-816348-1.00008-9

Stratégie de recherche translationnelle sur la maladie d’Alzheimer : cibles, modèles animaux et biomarqueurs

Dhénain, M. (2015) · Bulletin de l Académie Nationale de Médecine · doi:10.1016/s0001-4079(19)30893-3

Amyloidosis of the central nervous system: common features of various diseases

Silonov, S., & Zinych, I. (2019) · Ukrains kyi Visnyk Psykhonevrolohii · doi:10.36927/2079-0325-v27-is2-2019-3

Pathways of neurodegeneration underlying dementia

Buckley, N. J., & Tofaris, G. K. (2020) · doi:10.1093/med/9780198713005.003.0038

The Longitudinal Relationships between Biomarkers of Alzheimer’s Disease

Krance, S. H. (2019) · TSpace (University of Toronto)

The role of actin polymerization in model Hirano body formation

Dong, Y. (2015)

Prion Diseases

Silva, C. J. (2014) · ASM Press eBooks · doi:10.1128/9781555815486.ch24

Prions

Prusiner, S. B. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.00090-8

References

(2018) · Elsevier eBooks · doi:10.1016/b978-0-12-811351-6.00026-7

Faculty Opinions recommendation of Parkinson's disease and multiple system atrophy have distinct α-synuclein seed characteristics.

Petersen, R. B. (2019) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.734510478.793555621

Amyloid-β seeding effects are dependent on the presence of knock-in genes in the App NL-G-F micePreprint

Lacoursiere, S. G., Safar, J., Westaway, D. A., Mohajerani, M. H., & Sutherland, R. J. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.05.28.492382

Prions as Non-Canonical Hereditary Factors

Tikhodeyev, O. N. (2022) · Russian Journal of Genetics · doi:10.1134/s1022795422060126 · Cited by 1

SORL1 gene mutation and octapeptide repeat insertion in PRNP gene in a case presenting with rapidly progressive dementia and cerebral amyloid angiopathy

Cencini, F., Catania, M., Fede, G. D., Rossi, G., Chalouhi, K. K., Manfredi, C., Giaccone, G., Tiraboschi, P., Bersano, A., Groppo, E., et al. (2022) · European Journal of Neurology · doi:10.1111/ene.15487

Presymptomatic neuroanatomical and cognitive biomarkers of alpha-synuclein propagation in a mouse model of synucleinopathyPreprint

Tullo, S., de Miranda, A. S., del Cid‐Pellitero, E., Lim, M. P., Gallino, D., Attaran, A., Patel, R., Novikov, V., Park, M., Beraldo, F. H., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.10.12.511820

Aβ plaque deposition and microgliosis following Aβ seeding in AppNL-G-F mice is regionally distinctPreprint

Lacoursiere, S. G., Mohajerani, M. H., & Sutherland, R. J. (2022) · Research Square · doi:10.21203/rs.3.rs-2231253/v1

Cofactor Involvement in Prion Propagation

Supattapone, S., & Miller, M. B. (2023) · Springer eBooks · doi:10.1007/978-3-031-20565-1_8

Evaluating the transmission risk of amyloid beta peptide via ingestionPreprint

Raine, J., Tolwinski, N. S., Gruber, J., & Mathuru, A. S. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.08.03.551437

Dissimilar accumulation of human β-amyloid and tau from enriched extracts in neuronal and endothelial cellsPreprint

Rabanal‐Ruiz, Y., Pedrero-Prieto, C. M., Sanchez-Rodriguez, L., Flores‐Cuadrado, A., Saiz‐Sánchez, D., Frontiñán-Rubio, J., Úbeda‐Bañón, I., Durán‐Prado, M., Martı́nez-Marcos, A., & Peinado, J. R. (2023) · Research Square · doi:10.21203/rs.3.rs-3343553/v1

Cutaneous Amyloidoses

Schreml, S. (2024) · Wiley eBooks · doi:10.1002/9781119709268.rook056

Frontotemporal dementia-like disease progression elicited by seeded aggregation and spread of FUSPreprint

Vazquez‐Sanchez, S., Tilkin, B., Gasset-Rosa, F., Zhang, S., Piol, D., McAlonis‐Downes, M., Artates, J. W., Govea-Perez, N., Verresen, Y., Guo, L. E., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.06.03.593639

Production of Distinct Fibrillar, Oligomeric, and Other Aggregation States from Network Models of Multibody Interaction

Diessner, E. M., Thomas, L. J., & Butts, C. T. (2024) · Journal of Chemical Theory and Computation · doi:10.1021/acs.jctc.4c00916

S5‐03–03: Induction of cerebral beta‐amyloidosis in transgenic mice

Jucker, M. (2008) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2008.05.574

P1‐035: Exogenous induction of Abeta‐amyloidosis: Peripheral and stainless‐steel‐wire inoculations

Eisele, Y. S., Bolmont, T., Heikenwälder, M. F., Yan, Z.-X., Roth, K., Aguzzi, A., Staufenbiel, M., Walker, L. C., & Jucker, M. (2008) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2008.05.620

Induction of cerebral beta-amyloidosis: intracerebral versus systemic Abeta inoculation

Eisele, Y. S., Bolmont, T., Heikenwalder, M., Langer, F., Jacobson, L. H., Yan, Z. X., Roth, K., Aguzzi, A., Staufenbiel, M., Walker, L. C., et al. (2009) · Zurich Open Repository and Archive (University of Zurich) · doi:10.5167/uzh-26933 · Cited by 4

Induction of cerebral β-amyloidosis: Intracerebral versus systemic Aβ inoculation

Eisele, Y. S., Bolmont, T., Heikenwalder, M., Langer, F., Jacobson, L. H., Yan, Z.-X., Roth, K., Aguzzi, A., Staufenbiel, M., Walker, L. C., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0903200106 · Cited by 279

Exogenous seeding of cerebral β‐amyloid deposition in βAPP‐transgenic rats

Rosen, R. F., Fritz, J. J., Dooyema, J. M., Cintron, A. F., Hamaguchi, T., Lah, J. J., LeVine, H., Jucker, M., & Walker, L. C. (2011) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2011.07551.x · Cited by 126